Comparison of the effect of different inhibitors on the non-enzymatic glycation of rat tail tendons and bovine serum albumin

Annals of Clinical Biochemistry

Volumn 33, Issue 3, 1996, Pages 241-248

  Menzel, Ernst Johannes ^a,d   Reihsner, Roland ^b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aminoguanidine; Arginine lysine; Ibuprofen; Isometric thermal contraction; L arginine

Indexed keywords

AMINOGUANIDINE; ARGININE; BOVINE SERUM ALBUMIN; COLLAGEN; IBUPROFEN; LYSINE;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE; GLYCATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; RAT; TAIL; TEMPERATURE; TENDON; YOUNG MODULUS;

ANIMALIA; BOVINAE;

EID: 0029940201     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300311     Document Type: Article

References (25)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21
2. Ledl F, Schleicher E. Die nicht-enzymatische Glycosylierung von Proteinen. Angew Chemie 1990; 102: 597-626
3. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984; 81: 583-7
4. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exo-genous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 1992; 89: 12043-7
5. Shyadehi AZ, Harding JJ. Investigations of ibuprofen and paracetamol binding to lens proteins to explore their protective role against cataract. Biochem Pharmacol 1991; 42: 2077-84
6. Raza K, Harding JJ. Non enzymatic modifications of lens proteins by glucose and fructose: effect of ibuprofen. Expl Eye Res 1991; 52: 205-12
7. Oxlund H, Andreassen TT. Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetologia 1992; 35: 19-25
8. Nicholls K, Mandel TE. Advanced glycosylation end products in experimental murine diabetic nephropathy, effect of islet isografting and of aminoguanidine. Lab Invest 1989; 60: 486-93
9. Sensi M, Pricci F, Rossi MG, Morano S, DiMario U. D-lysine effectively decreases the non-enzymatic glycation of proteins in vitro. Clin Chem 1989; 35: 384-7
10. Menzel EJ, Reihsner R. Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine. Diabetologia 1991; 34: 12-16
11. Daniels BS, Hauser EG. Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model. Diabetes 1992; 41: 1415-21
12. LePape A, Guitton JD, Muh JP. Influence of in vitro non-enzymatic glycosylation on the physiochemical parameters of type I collagen. FEBS Lett 1984; 170: 23-7
13. Stegemann H, Stalder KH. Determination of hydroxy-proline. Clin Chim Acta 1967; 18: 267-73
14. Millesi H, Reihsner R, Hamilton G, Mallinger R, Menzel EJ. Biomechanical properties of normal tendons, normal palmar aponeuroses, and tissues from patients with Dupuytren's disease subjected to elastase and chondroitinase treatment. Clin Biomech 1995; 10: 29-35
15. Alain JC, LeLous M, Bazin S, Bailey A, Delaunay A. Isometric tensions developed during heating of collagenous tissues. Relationships with collagen crosslinking. Biochim Biophys Acta 1978; 533: 147-55
16. Khaidar A, Marx M, Lubec B, Lubec G. L-arginine reduces heart collagen accumulation in the diabetic db/dh mouse. Circulation 1994; 90: 479-83
17. Lubec G, Bartosch B, Mallinger R, Adamiker D, Graef I, Frisch M, et al. The effect of substance L on glucose-mediated cross-links of collagen in the diabetic db/db mouse. Nephron 1990; 56: 281-4
18. Tsao PS, Theilmeier G, Singer AH, Leung LK, Cooke JP. L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 1529-33
19. Nagy ZS, Toth VN, Verzar F. High-resolution electron microscopy of thermal collagen denaturation in rat tail tendons of young, adult and old rats. Conn Tiss Res 1974; 2: 265-72
20. Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA. Stereoselective plasma protein binding of ibuprofen enantiomers. Eur J Clin Pharmacol 1989; 36: 283-90
21. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes induced arterial wall protein cross-linking. Science 1986; 232: 1629-32
22. Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation end products inhibition by aminoguanidine. Diabetes 1992; 41: 26-9
23. Chibber R, Molinati PA, Wong JS, Mirlees D, Kohner EM. The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 1994; 43: 758-63
24. Holstad M, Sandler S. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 1993; 15: 311-14
25. Ou P, Wolff SP. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 1993; 46: 1139-44